Acme United Clocks 5.8% Sales Growth In Q1 Backed By Solid Customer Base, New Product Launches

  • Acme United Corporation ACU reported first-quarter FY23 net revenue growth of 5.8% year-on-year to $45.84 million, beating the analyst consensus of $44.63 million.
  • The company attributed the sales growth to the expansion of its customer base and new product introductions in the first aid and medical segment.
  • Sales in the U.S. segment increased 9% Y/Y. Net sales in Canada decreased by 10%, mainly due to retailer inventory reductions, while it fell by 6% in Europe. 
  • Gross margin expanded to 35.5% for the quarter versus 34.5% last year on cost-saving initiatives implemented in the fall of 2022.
  • Operating margin expanded 161 basis points to 4.8% in the quarter under review, while the operating income jumped 59.6% to $2.19 million.
  • Cash and equivalents amounted to $2.76 million as of March 31, 2023.
  • Net income rose 19.3% Y/Y to $990,000. EPS increased 27.3% to $0.28, missing the analyst consensus of $0.44.
  • Continued inventory reductions by some large mass market customers partially hampered overall quarterly performance.
  • "The Company is on track to realize projected annual savings of $5 million in 2023 due to the many productivity improvements we have been implementing," said CEO Walter C. Johnsen. "We look forward to growth and improved profitability in 2023."
  • Price Action: ACU shares are trading higher by 0.76% at $25.10 on the last check Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsEquitiesNewsHealth CareMarketsGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!